AKT Inhibitor VIII, >97.0%(HPLC), 25mg

4-(4-chloro-2-fluorobenzoyl)-8-ethyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

2-(3-BROMOPHENYL)PYRROLIDINE, 95.0%, 1g

5-fluoro-4-hydrazino-2-methoxypyrimidine, 95.0%, 500g

(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol, 97%, 1g

Oxyde de lanthane(III), 99,99 %, pa, 50 g, emballage plastique.

tert-Butyl (5-iodo-2-methoxyphenyl)carbamate, 97%, 250mg

4-{2-Methyl-3H-imidazo[4,5-b]pyridin-3-yl}piperidine dihydrochloride, 250mg

N-(2-(1H-Indol-3-yl)ethyl)nicotinamide, 95.0%, 50mg

ETHYLDIPHENYLSULFONIUM TETRAFLUOROBORATE, 95%, 250mg

2-(Benzyloxy)-5-chloropyridine, 98%, 1g

Methyl 8-bromooctanoate, 97%, 1g

6-hydrazinoimidazo[1,2-b]pyridazine, 95.0%, 250mg